Home
Contact ARYx
Site Map
Search
About ARYx
Making Safer Drugs
Product Improvements
Intellectual Property
Products
Naronapride (ATI-7505) - Gastrointestinal Disorders
Budiodarone (ATI-2042) - Atrial Fibrillation
Tecarfarin (ATI-5923) - Anticoagulation
ATI-9242 - Psychiatric Disorders
Future Applications
Partners
Partnering Opportunities
Partnering Information
Investors
Stock Performance
Careers
Mission Statement
Current Opportunities
Board of Directors
Paul Goddard, Ph.D.
Chairman & Chief Executive Officer
Nick Simon, M.B.A.
Mission Statement
Executive Management
Board of Directors
Paul Goddard, Ph.D.
Nick Simon, M.B.A.
Corporate Presentation
